Skip to main content

Hypertensive Urgencies and Emergencies

  • Chapter
  • First Online:
  • 858 Accesses

Abstract

Hypertensive urgencies and emergencies occur in the general population as well as patients with chronic kidney disease. The epidemiology, pathophysiology, and approach to patients with hypertensive urgencies and emergencies are discussed. The specific approach to the chronic kidney disease population is also outlined throughout the chapter, including various case illustrations. Oral and parenteral medications used specifically for hypertensive urgency/emergency are reviewed, including preferred therapies for specific clinical scenarios. Recognizing a true hypertensive urgency and emergency, treating the patient safely, but quickly, and determining the cause of escalated blood pressure are pivotal.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Notes

  1. 1.

    Not used in hypertensive emergencies in the general population, but may be considered in the CKD population if eveidence of volume overload.

References

  1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–23.

    Article  PubMed  Google Scholar 

  2. Marik PE, Rivera R. Hypertensive emergencies: an update. Curr Opin Crit Care. 2011;17:569–80.

    Article  PubMed  Google Scholar 

  3. Marik PE, Varon J. Hypertensive crises: challenges and management. Chest. 2007;131:1949–62.

    Article  CAS  PubMed  Google Scholar 

  4. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–47.

    Article  CAS  PubMed  Google Scholar 

  5. Sarafidis PA, Bakris GL. Evaluation and treatment of hypertensive urgencies and emergencies. In: Johnson R, Feehally J, Floege J, editors. Comprehensive clinical nephrology. 5th ed. Philadelphia: Elsevier Saunders; 2014. p. 439–46.

    Google Scholar 

  6. Ram C, Venkata S. Hypertensive urgencies and emergencies: considersations for treatment. In: Weir MR, editor. Hypertension. Philadelphia: American College of Physicians; 2005. p. 203–20.

    Google Scholar 

  7. Muiesan ML, Salvetti M, Amadoro V, et al. An update on hypertensive emergencies and urgencies. J Cardiovasc Med (Hagerstown). 2015;16:372–82.

    Article  Google Scholar 

  8. Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet. 2000;356:411–7.

    Article  CAS  PubMed  Google Scholar 

  9. Derhaschnig U, Testori C, Riedmueller E, Aschauer S, Wolzt M, Jilma B. Hypertensive emergencies are associated with elevated markers of inflammation, coagulation, platelet activation and fibrinolysis. J Hum Hypertens. 2013;27:368–73.

    Article  CAS  PubMed  Google Scholar 

  10. Carlstrom M, Wilcox CS, Arendshorst WJ. Renal autoregulation in health and disease. Physiol Rev. 2015;95:405–511.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Loutzenhiser R, Griffin KA, Bidani AK. Systolic blood pressure as the trigger for the renal myogenic response: protective or autoregulatory? Curr Opin Nephrol Hypertens. 2006;15:41–9.

    Article  PubMed  Google Scholar 

  12. Bidani AK, Griffin KA, Williamson G, Wang X, Loutzenhiser R. Protective importance of the myogenic response in the renal circulation. Hypertension. 2009;54:393–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Loutzenhiser R, Griffin K, Williamson G, Bidani A. Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms. Am J Physiol Regul Integr Comp Physiol. 2006;290:R1153–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Khawaja Z, Wilcox CS. Role of the kidneys in resistant hypertension. Int J Hypertens. 2011;2011:143471.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Inrig JK. Intradialytic hypertension: a less-recognized cardiovascular complication of hemodialysis. Am J Kidney Dis. 2010;55:580–9.

    Article  CAS  PubMed  Google Scholar 

  16. Singapuri MS, Lea JP. Management of hypertension in the end-stage renal disease patient. J Clin Outcomes Manage. 2010;17:87–95.

    Google Scholar 

  17. Pak KJ, Hu T, Fee C, Wang R, Smith M, Bazzano LA. Acute hypertension: a systematic review and appraisal of guidelines. Ochsner J. 2014;14:655–63.

    PubMed  PubMed Central  Google Scholar 

  18. Elliott WJ. Hypertensive emergencies. Crit Care Clin. 2001;17:435–51.

    Article  CAS  PubMed  Google Scholar 

  19. Grossman E, Messerli FH, Grodzicki T, Kowey P. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA. 1996;276:1328–31.

    Article  CAS  PubMed  Google Scholar 

  20. Michael J, Groshong T, Tobias JD. Nicardipine for hypertensive emergencies in children with renal disease. Pediatr Nephrol. 1998;12:40–2.

    Article  CAS  PubMed  Google Scholar 

  21. Neutel JM, Smith DH, Wallin D, et al. A comparison of intravenous nicardipine and sodium nitroprusside in the immediate treatment of severe hypertension. Am J Hypertens. 1994;7:623–8.

    CAS  PubMed  Google Scholar 

  22. Deeks ED, Keating GM, Keam SJ. Clevidipine: a review of its use in the management of acute hypertension. Am J Cardiovasc Drugs. 2009;9:117–34.

    Article  CAS  PubMed  Google Scholar 

  23. Grossman E, Ironi AN, Messerli FH. Comparative tolerability profile of hypertensive crisis treatments. Drug Saf. 1998;19:99–122.

    Article  CAS  PubMed  Google Scholar 

  24. Hirschl MM, Binder M, Bur A, et al. Clinical evaluation of different doses of intravenous enalaprilat in patients with hypertensive crises. Arch Intern Med. 1995;155:2217–23.

    Article  CAS  PubMed  Google Scholar 

  25. Murphy MB, Murray C, Shorten GD. Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. N Engl J Med. 2001;345:1548–57.

    Google Scholar 

  26. Oparil S, Aronson S, Deeb GM, et al. Fenoldopam: a new parenteral antihypertensive: consensus roundtable on the management of perioperative hypertension and hypertensive crises. Am J Hypertens. 1999;12:653–64.

    Article  CAS  PubMed  Google Scholar 

  27. Prisant LM. Pharmacology of antihypertensive drugs. In: Weir MR, editor. Hypertension. Philadelphia: American College of Physicians; 2005. p. 89.

    Google Scholar 

  28. Daugirdas JT, Blake PG, Ing TS. Handbook of dialysis. 5th ed. Lippincott Williams & Wilkins; 2014.

    Google Scholar 

  29. Gales MA. Oral antihypertensives for hypertensive urgencies. Ann Pharmacother. 1994;28:352–8.

    CAS  PubMed  Google Scholar 

  30. Judd E, Calhoun DA. Management of hypertension in CKD: beyond the guidelines. Adv Chronic Kidney Dis. 2015;22:116–22.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matthew R. Weir MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Trivedi, H.K., Patel, D., Weir, M.R. (2016). Hypertensive Urgencies and Emergencies. In: Singh, A., Agarwal, R. (eds) Core Concepts in Hypertension in Kidney Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-6436-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6436-9_9

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-6434-5

  • Online ISBN: 978-1-4939-6436-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics